Abstract-An in vivo experimental strategy, involving cardiac-specific expression of a mutant Kv 2.1 subunit that functions as a dominant negative, was exploited in studies focused on exploring the role of members of the Kv2 subfamily of pore-forming (␣) subunits in the generation of functional voltage-gated K ϩ channels in the mammalian heart. A mutant Kv2.1 ␣ subunit (Kv2.1N216) was designed to produce a truncated protein containing the intracellular N terminus, the S1 membrane-spanning domain, and a portion of the S1/S2 loop. The truncated Kv2.1N216 was epitope tagged at the C terminus with the 8 -amino acid FLAG peptide to generate Kv2.1N216FLAG. No ionic currents are detected on expression of Kv2.1N216FLAG in HEK-293 cells, although coexpression of this construct with wild-type Kv2.1 markedly reduced the amplitudes of Kv2.1-induced currents. Using the ␣-myosin heavy chain promoter to direct cardiac specific expression of the transgene, 2 lines of Kv2.1N216FLAG-expressing transgenic mice were generated. Electrophysiological recordings from ventricular myocytes isolated from these animals revealed that I K, slow is selectively reduced. The attenuation of I K, slow is accompanied by marked action potential prolongation, and, occasionally, spontaneous triggered activity (apparently induced by early afterdepolarizations) is observed. The time constant of inactivation of I K, slow in Kv2.1N216FLAG-expressing cells (meanϮSEMϭ830Ϯ103 ms; nϭ17) is accelerated compared with the time constant of I K, slow inactivation (meanϮSEMϭ1147Ϯ57 ms; nϭ25) in nontransgenic cells. In addition, unlike I K, slow in wild-type cells, the component of I K, slow remaining in the Kv2.1N216FLAG-expressing cells is insensitive to 25 mmol/L tetraethylammonium. Taken together, these observations suggest that there are 2 distinct components of I K, slow in mouse ventricular myocytes and that Kv2 ␣ subunits underlie the more slowly inactivating, tetraethylammonium-sensitive component of I K, slow . In vivo telemetric recordings also reveal marked QT prolongation, consistent with a defect in ventricular repolarization, in Kv2.1N216FLAG-expressing transgenic mice. (Circ Res. 1999;85:623-633.)
The DNA sequence (residues 1 to 648) encoding the intracellular N terminus, the S1 membrane spanning region, and a portion of the S1/S2 extracellular loop of Kv2.1 was amplified by polymerase chain reaction (PCR). The PCR primers used (in this reaction) introduced 5Ј SalI and 3Ј EcoRI sites; the 648-bp PCR product was then digested with SalI and EcoRI and subcloned into pBK-CMV (Stratagene). To epitope (FLAG) tag the truncated Kv2.1 sequence at the 3Ј end, 2 oligonucleotides corresponding to the sense and antisense strands of the 8 -amino acid FLAG epitope were designed to contain EcoRI and XhoI overhangs at the 5Ј and 3Ј ends, respectively; these were generated by the Protein and Nucleic Acid Facility at Washington University Medical School. The annealed oligonucleotides were subcloned into pBK-CMV-Kv2.1(1 to 648) at the EcoRI and XhoI sites. The entire Kv2.1N216FLAG construct was sequenced, and no errors were detected.
Cell Lines and Transient Transfections
HEK-293 cells, from a human embryonic kidney cell line, which were obtained from the Washington University Medical School Tissue Culture Support Center, were maintained in MEM supplemented with 5% horse serum, 5% FCS, 100 U/mL penicillin, 100 U/mL stroptomycin, and 0.15% mycostatin. HEK-293 cells were transferred to serum-free MEM with 24 hours of passage and transiently transfected using calcium-phosphate with plasmids encoding Kv2.1, Kv1.4, or Kv2.1N216FLAG, together with the green fluorescent protein (GFP) (pGREENLANTERN; GIBCO-BRL); inclusion of the plasmid encoding GFP allowed transfected cells to be identified before electrophysiological recordings. Approximately 15 hours after transfection, the cells were washed and allowed to recover for 20 to 24 hours before electrophysiological recordings.
Generation of Transgenic Mice Expressing ␣-MHC-Kv2.1N216FLAG
The Kv2.1N216FLAG coding sequence was digested from pBK-CMV-Kv2.1N216FLAG with SalI and XhoI and subcloned into the ␣-MHC vector 36 -39 at the SalI site; restriction enzyme digests were performed to select for the proper orientation. The ␣-MHCKv2.1N216FLAG plasmid was digested with NotI to isolate a 5.7-kb fragment that included the 3Ј exon from the ␤-MHC gene, intergenic sequences, the ␣-MHC promoter, the first 3 noncoding exons of the ␣-MHC gene, the Kv2.1N216FLAG coding sequence, and the human growth hormone (HGH) polyadenylation signal sequences. 36 -39 After electrophoresis through a 1% agarose gel, this (5.7-kB) fragment was isolated and an equal volume of 0.3 mol/L NaCl/Tris-EDTA (TE) was added. After melting at 65°C for 30 minutes, the mixture was extracted with phenol:chloroform:isoamyl alcohol (25:24:1), and the DNA was ethanol precipitated. The DNA was then suspended in 1 mL 0.2 mol/L NaCl/TE, purified over a Prepac column and ethanol precipitated. The recovered DNA was resuspended in 100 L of injection buffer (10 mmol/L Tris buffer containing 10 mmol/L NaCl and 0.1 mmol/L EDTA at pH 7.4), dialyzed against a 0.1 m Millipore filter, and diluted to a final concentration of 1 ng/L for injection into fertilized C57BL/6 mouse blastocysts. After the (Ϸ100) injections, the oocytes were transplanted into pseudopregnant ICR adult mice. A total of 37 offspring were obtained, and all were screened for expression of the transgene by PCR analysis of (tail) genomic DNA using probes directed against the HGH polyadenylation sequence (in the ␣-MHC vector). 36 -39 Two animals positive for the transgene were identified (see Results). At 8 weeks, these animals were bred to wild-type C57BL/6 adult mice, and 2 lines of Kv2.1N216FLAG transgenic mice were established.
Expression of Kv2.1 and Kv2.1N216FLAG in Mouse Ventricles
For reverse transcription (RT)-PCR (RT-PCR) analysis, mRNA was prepared from the ventricles and brains of adult Kv2.1N216FLAG-expressing transgenic and nontransgenic (control) littermates using the Micro-FasTrack mRNA isolation kit (Invitrogen). cDNA was synthesized in a 20-L reaction mixture containing (in mmol/L) Tris-HCl (pH 8.3) 50, MgCl 2 5, KCl 75, sodium pyrophosphate 4, dNTPs 5, and DTT 10, as well as 0.5 g of oligo(dT) [12] [13] [14] [15] [16] [17] [18] , 0.2 g of mRNA, 10 units of RNase inhibitor, and 5 units of avian myeloblastosis virus reverse transcriptase (Invitrogen). After a 1-hour incubation at 42°C, the reaction was terminated by heating at 95°C for 2 minutes. Approximately 2 L of the resulting reaction mixture was used for PCR amplification. PCR was carried out in a 25-L reaction mixture containing (in mmol/L) Tris-HCl (pH 9.0) 10, KCl 50, MgCl 2 2, DTT 1, and dNTPs 0.2, as well as 0.5 mol/L of each primer (see below), and 1 unit of Taq DNA polymerase (Sigma). The reaction proceeded for 30 cycles as follows: 94°C for 30 seconds and 58°C for 45 seconds, followed by 68°C for 90 seconds. The forward and reverse primers used for RT-PCR to probe for actin, wild-type Kv2.1, and Kv2.1N216FLAG were 5Ј-GTGTTACGTCGCCCTT-GATT-3Ј and 5Ј-GCTGGAGGTGGACAGAGAG-3Ј (actin), 5Ј-CCGAGACCAGCTCCAGTAAG-3Ј and 5Ј-CTCCACGAAGAAA-CCAAGC-3Ј (wild-type Kv2.1), and 5Ј-TTCAGCCAGGAGC-TGGACTA-3Ј and 5Ј-CTTGTCATCTGCGTCCTTGTAGTC-3Ј (Kv2.1N216FLAG). The amplified PCR products were analyzed in a 1% agarose gel and stained with ethidium bromide.
Mouse ventricular membrane proteins were prepared using a protocol previously developed for the isolation of rat cardiac membrane proteins. 40, 41 After fractionation by SDS-PAGE and transfer to polyvinylidene difluoride membranes (Amersham), immunoblots were completed with a monoclonal anti-FLAG M2 antibody (Eastman Kodak) diluted 1:500 or with a polyclonal anti-Kv2.1 antibody (Upstate Biotechnology Inc, Lake Placid, NY), diluted 1:300, followed by an alkaline phosphatase-conjugated goat anti-mouse (to detect the FLAG antibody) or goat anti-rabbit secondary antibody (to detect the Kv2.1 antibody). Bound antibodies were detected using the CPSD (Tropix) chemiluminescent alkaline phosphatase substrate. 40, 41 
Electrophysiological Recordings
Whole-cell voltage-clamp recordings from GFP-positive HEK-293 cells were obtained at room temperature Ϸ48 hours after transfections. The recording pipettes contained (in mmol/L) KCl 115, KOH 15, EGTA 10, HEPES 10, and glucose 5 (pH 7.2; 300 to 310 mOsm). The bath solution contained (in mmol/L) NaCl 140, KCl 4, MgCl 2 2, CaCl 2 1, HEPES 10, and glucose 5 (pH 7.4; 300 to 310 mOsm). Experiments were performed using an Axopatch 1B patch-clamp amplifier (Axon Instruments) interfaced to a Gateway 350-MHz Pentium computer interfaced to the recording equipment with a Digidata 1200 analog/digital interface and the pClamp 7 software package (Axon Instruments). Data were filtered at 5 kHz before storage. Recording electrodes were fabricated from soda lime glass (Kimble), coated with Sylgard (Dow Corning) and fire-polished; tip resistances were 1.5 to 2.5 M⍀. Series resistances were in the range of 3 to 4 M⍀ and were compensated electronically by 80% to 90%; voltage errors resulting from the uncompensated series resistance were Յ8 mV and were not corrected. Outward K ϩ currents in transiently transfected HEK-293 cells were evoked during 140-ms depolarizing voltage steps to test potentials between Ϫ40 and ϩ60 mV from a holding potential (HP) of Ϫ70 mV.
Ventricular myocytes were isolated from adult transgenic and wild-type animals as described previously. 15, 19, 20, 23 Electrophysiological experiments were conducted as described above for HEK-293 cells at room temperature on the day of cell isolation. For voltageclamp experiments, the bath solution contained (in mmol/L) NaCl 136, KCl 4, CaCl 2 1, MgCl 2 2, CoCl 2 5, HEPES 10, glucose 10, and 0.02 tetrodotoxin (TTX) (pH 7.4; 295 to 300 mOsm); TTX and Co 2ϩ were eliminated when action potentials were recorded. For both current-and voltage-clamp experiments, the recording pipette solution contained (in mmol/L) KCl 135, EGTA 10, HEPES 10, and glucose 5 (pH 7.2; 295 to 310 mOsm). Outward K ϩ currents were evoked during 500-ms or 4.5-second voltage steps to test potentials between Ϫ40 and ϩ60 mV from a HP of Ϫ70 mV after a 20-ms prepulse to Ϫ20 mV (to eliminate the TTX-insensitive voltage-gated Na ϩ current). Inwardly rectifying K ϩ currents (I K1 ) were evoked during hyperpolarizing voltage steps to test potentials between Ϫ90 and Ϫ120 mV.
Electrocardiograms
Electrocardiographic recordings were obtained from adult Kv2.1N216FLAG-expressing transgenic mice and from nontransgenic littermates using Data Sciences International implantable Physiotel TA10ETA-F20 radio frequency transmitters and receivers (placed under the cage). To implant the transmitters, animals were first anesthetized by intraperitoneal injection of ketamine (80 mg/kg) and xylazine (16 mg/kg). After opening the chest, transmitters were placed in the abdominal cavity, and the electrocardiographic leads were tunneled under the skin, sutured, and glued (veterinary tissue adhesive) to muscles in the thorax. Cathodal leads were routinely placed on the upper right portion of the thorax, and anodal leads were placed on the chest wall near the apex of the heart. After implantation of the transmitters, the animals were allowed to recover for 24 hours before recording electrocardiographic data. Analog electrocardiographic signals were collected, digitized at 1 kHz using a 16-bit Dataquest A.R.T. Gold Acquisition analog-to-digital converter (Data Sciences), and stored on CD-ROM disks. Three-minute electrocardiographic recordings every hour for 10 consecutive hours were obtained from each transgenic (nϭ7) and nontransgenic (nϭ5) animal; all animals were monitored for 5 consecutive days. Unfiltered data were analyzed, and QT, QRS, and RR intervals were measured; average values for individual animals were determined; meanϮSEM values for experiments completed on transgenic (nϭ7) and nontransgenic (nϭ5) animals are reported here.
Data Analysis
Voltage-clamp and current-clamp data were compiled and analyzed using Clampfit (Axon Instruments) and Excel (Microsoft). For each cell, the spatial control of the membrane voltage was assessed by analyzing the decays of the capacitative transients evoked during subthreshold Ϯ10 mV voltage steps from the HP (Ϫ70 mV); only cells with capacitative transients well described by single exponentials were analyzed further. Whole-cell ventricular myocyte membrane capacitances were determined by integration of the capacitative transients evoked during brief (25-ms) subthreshold (Ϯ10 mV) voltage steps from a HP of Ϫ70 mV. MeanϮSEM whole-cell membrane capacitances of cells isolated from wild-type and transgenic animals were 140Ϯ7 pF (nϭ25) and 175Ϯ13 pF (nϭ17) in wild-type and Kv2.1N216FLAG-expressing cells, respectively. The meanϮSEM input resistances of adult mouse wild-type (nϭ25) and Kv2.1N216FLAG-expressing (nϭ17) ventricular myocytes were 0.90Ϯ0.23 G⍀ and 0.65Ϯ0.20 G⍀, respectively. Leak currents were always Ͻ100 pA and were not corrected. The plateau outward K ϩ current was defined as the current remaining 3 seconds after the onset of the depolarizing voltage steps, and the peak outward current was defined as the maximum value of the outward K ϩ current during 200-ms voltage steps. Current amplitudes, measured in individual cells, were normalized to cell size (whole-cell membrane capacitance), and current densities (in pA/pF) are reported.
The time constants of inactivation of the depolarization-activated outward K ϩ currents in wild-type and Kv2.1N216FLAG-expressing ventricular myocytes were determined from double exponential fits to the decay phases of the current, using the following equation: A t ϭA 1 ϫexp(Ϫt/ 1 )ϩA 2 ϫexp(Ϫt/ 2 )ϩA ss , where A t is the amplitude of the current at time t, A 1 and 1 and A 2 and 2 represent the amplitudes (A) and the time constants () of the fast and slow components of current decay, and A ss is the amplitude of the noninactivating (steady-state) component of the total outward K ϩ current. Correlation coefficients were determined to assess the quality of the fits; in all cases, correlation coefficients were Ն0.980. For analysis of ECGs, the onsets and offsets of the P, Q, R, S, and T waves were determined by measuring the earliest (onset) and the latest (offset) times from the 2 leads. Measured QT intervals were corrected for differences in heart rate using the formula QT c ϭQT o / (RR/100) 1/2 , as described by London et al. 32 All data are presented as meanϮSEM unless otherwise noted. Differences between wild-type and Kv2.1N216FLAG-expressing myocytes were analyzed using ANOVA and the Student's t test; probability value are presented in the text.
Results

Generation and Characterization of the Dominant-Negative Kv2.1 Construct, Kv2.1N216
To generate the Kv2 dominant negative construct, mutations were introduced to the cDNA sequence to place a stop codon at amino acid residue 216; this approach is similar to that used by Folco et al 35 in the development of Kv1.1N206Tag. The dominant-negative Kv2 construct is referred to as Kv2.1N216 ( Figure 1A ). The truncated Kv2 subunit was tagged at the C terminus with the 8 -amino acid FLAG epitope to allow direct detection of expression of the transgene. When transfected into HEK-293 cells, expression of Kv2.1N216FLAG was readily detected immunohistochemically using an anti-FLAG M2 antibody (data not shown). As expected, no outward K ϩ currents were evident in whole-cell voltage-clamp recordings from Kv2.1N216FLAG-expressing HEK-293 cells ( Figure  1B ). When the plasmid encoding Kv2.1N16FLAG is cotransfected with wild-type (full-length) Kv2.1, however, the densities of the Kv2.1-induced currents are markedly reduced ( Figure 1D ) compared with cells expressing wild-type Kv2.1 alone ( Figure 1C ). The meanϮSEM peak outward K ϩ current densities at ϩ60 mV in HEK-293 cells expressing wild-type Kv2.1 alone and wild-type Kv2.1 plus Kv2.1N216FLAG were 403Ϯ74 pA/pF (nϭ11) and 117Ϯ28 pA/pF (nϭ9), respectively; these values are significantly (PϽ0.001) different. The voltage dependences and the rates of activation and inactivation of the Kv2.1-induced currents in the absence (nϭ11) and in the presence (nϭ9) of Kv2.1N216FLAG, however, are indistinguishable. These observations suggest that the assembly of wild-type subunits with the truncated Kv2.1N216FLAG leads to the generation of nonfunctional channels rather than to channels with altered time-and/or voltage-dependent properties.
In contrast to the effects on Kv2.1-induced currents, coexpression of Kv2.1N216FLAG with Kv1.4, a member of the Shaker subfamily that is not expected to assemble with subunits of the Kv2 subfamily, 42 however, has no measurable effect on the Kv1.4-induced currents ( Figure 1E and 1F). The meanϮSEM peak outward K ϩ current densities at ϩ60 mV in HEK-293 cells expressing Kv1.4 alone and Kv1.4 plus Kv2.1N216 were 204Ϯ52 pA/pF (nϭ8) and 194Ϯ36 pA/pF (nϭ8), respectively; these values are not significantly different.
Generation and Characterization of Transgenic Mice Expressing Kv2.1N216FLAG
For the generation of transgenic mice expressing Kv2.1N216FLAG, the FLAG-tagged Kv2.1N216 DNA sequence was subcloned downstream of the cardiac-specific ␣-MHC promoter in the ␣-MHC expression vector (generously provided to us by Dr Jeffery Robbins, University of Cincinnati, Ohio). Previous work has documented that this promoter is cardiac specific and that constitutive expression of ␣-MHC, as well as transgenes driven by this promoter, are detected in mouse ventricles (and atria) from the time of birth. 36 -39 A 5.7-kb fragment containing the ␣-MHC promoter, the Kv2.1N216FLAG sequence, and the HGH polyadenylation signal sequence was isolated and injected into C57BL/6 mouse blastocysts. For screening, genomic tail DNA was prepared, and transgene incorporation was assayed by PCR using probes directed against the HGH polyadenylation signal sequence. Two founders (Nos. 5 and 6) were identified and were bred to wild-type C57BL/6 mice to generate 2 lines of Kv2.1N216FLAG-expressing transgenic mice.
Initial analysis of the functional consequences of Kv2.1N216FLAG expression were completed on the F 1 progeny of founder No. 5. As illustrated in Figure 2B , PCR analysis revealed that Kv2.1N216FLAG, as well as wild-type Kv2.1, expression is readily detected in the ventricles of line No. 5 transgenic animals, whereas only wild-type Kv2.1 is detected in the ventricles of nontransgenic littermates. In addition, in brains isolated from Kv2.1N216FLAG-expressing transgenic mice, only wild-type Kv2.1 is evident ( Figure 2B) , consistent with the cardiac-specific expression of the transgene. 36 -39 Expression of the Kv2.1N216FLAG protein was also readily detected in Western blots of fractionated ventricular membrane proteins 40, 41 from line 5 transgenic mice ( Figure 2C ). Using an antibody targeted against the C terminus of Kv2.1, the full-length, endogenous Kv2.1 protein is evident in Western blots of fractionated mouse ventricular membrane proteins from both wild-type and transgenic animals ( Figure 2C ). In addition, and in contrast to the findings of London et al 32 with the truncated Kv1.1N206Tag, expression of the Kv2.1N216FLAG does not to result in a detectable decrease in the amount of full-length Kv2.1 protein in the ventricles of the transgenic animals relative to wild-type hearts (Figure 2Cb ) (see Discussion).
On gross examination, no obvious differences between the Kv2.1N216FLAG-expressing transgenic animals and their nontransgenic littermates were noted. MeanϮSD body weights, for example, were 25.9Ϯ3.0 g (nϭ7) and 25.9Ϯ3.7 g (nϭ7) for adult (20 week) wild-type and Kv2.1N216FLAG-expressing animals; these values are not significantly different. Heart weights were also not significantly different, with meanϮSD values of 102Ϯ12 mg (nϭ7) and 107Ϯ18 mg (nϭ7) for wild-type and Kv2.1N216FLAG-expressing animals, respectively. Heart-to-body weight ratios in nontransgenic and transgenic animals, therefore, were also very similar, and histological examination of hearts from Kv2.1N216FLAG-expressing animals revealed no significant differences from controls. Interestingly, however, there is a small but statistically significant (PϽ0.05) difference in the meanϮSEM input resistances and whole-cell membrane capacitances of ventricular myocytes isolated from Kv2.1N216FLAG-expressing and wild-type animals. MeanϮSEM whole-cell membrane capacitances of cells isolated from wild-type and transgenic animals were 140Ϯ7 pF (nϭ25) and 175Ϯ13 pF (nϭ17) in wild-type and Kv2.1N216FLAG-expressing cells, respectively, and meanϮSEM input resistances of adult mouse wild-type (nϭ25) and Kv2.1N216FLAG-expressing (nϭ17) ventricular myocytes were 0.90Ϯ0.23 G⍀ and 0.65Ϯ0.20 G⍀, respectively. These findings suggest that, despite the absence of gross changes in heart size and/or appearance, Kv2.1N216FLAG expression does have a small, but measurable, effect on the properties of individual mouse ventricular cells (see Discussion).
Outward K ؉ Currents are Attenuated in Kv2.1N216FLAG-Expressing Ventricular Myocytes
Whole-cell voltage-clamp recordings revealed that the waveforms of the depolarization-activated outward K ϩ currents in ventricular myocytes isolated from wild-type and transgenic littermates are distinct (Figure 3 ). Peak outward K ϩ current amplitudes at all test potentials, for example, are lower in cells isolated from Kv2.1N216FLAG-expressing transgenic animals ( Figure 3C and 3D) compared with the currents typically recorded in myocytes isolated from nontransgenic (wild-type) littermates ( Figure 3A and 3B) . Similar results were obtained in 17 myocytes from 2 Kv2.1N216FLAG transgenic animals derived from line 5, and the mean (ϮSEM) peak outward densities at ϩ40 mV were 50.4Ϯ4.4 pA/pF (nϭ25) and 36.8Ϯ3.8 pA/pF (nϭ17) in wild-type and Kv2.1N216FLAG-expressing myocytes, respectively (Table 1) ; these values are significantly (PՅ0.05) different. In contrast to the observed reductions in peak outward K ϩ current densities in ventricular myocytes isolated from the Kv2.1N216FLAG-expressing transgenic animals, no measurable effects on the densities of either the steady-state outward K ϩ currents, I ss , determined as the currents remaining at the end of 4.5 s voltage steps, 15 or of the hyperpolarization-activated, inwardly rectifying K ϩ current, I K1 , were observed. MeanϮSEM I ss densities at ϩ40 mV, for example, were 6.3Ϯ0.5 pA/pF (nϭ25) and 5.0Ϯ0.5 pA/pF (nϭ17) in wild-type and Kv2.1N216FLAG-expressing myocytes, respectively (Table 1) . MeanϮSEM peak I K1 densities evoked at Ϫ120 mV from a HP of Ϫ70 mV in wild-type and Kv2.1N216FLAG-expressing myocytes were 11.5Ϯ0.5 pA/pF (nϭ25) and 10.9Ϯ0.9 pA/pF (nϭ17), respectively.
I K, slow Is Altered Selectively in Kv2.1N216FLAG-Expressing Ventricular Myocytes
In wild-type adult mouse ventricular myocytes, analysis of the decay phases of the outward K ϩ currents evoked during Figure 3E . Analysis of the waveforms of the depolarization-activated K ϩ currents in ventricular myocytes isolated from Kv2.1N216FLAG-expressing littermates revealed that the decay phases of the currents were also well described by the sum of 2 exponentials. In this case, however, the meanϮSEM (nϭ17) decay time constants were 66Ϯ4 ms and 830Ϯ103 ms (Table 1) and, similar to the findings in wild-type cells, 15, 23, 34 neither time constant varies with voltage. Importantly, the time constant (of 66Ϯ4 ms) for the fast component of current decay in Kv2.1N216FLAG-expressing transgenic mouse ventricular myocytes, which reflects I to, f , 15, 23 is not significantly different from that determined in wild-type cells (meanϮSEM decay ϭ74Ϯ3 ms). The meanϮSEM time constant of inactivation of the slower component of current decay ( decay ϭ830Ϯ103 ms) in the Kv2.1N216FLAG-expressing cells, in contrast, is significantly (PϽ0.05) faster than the meanϮSEM decay of 1147Ϯ57 ms (Table 1) for I K, slow 15,23,34 in wild-type cells. This finding suggests either that I K, slow inactivation is accelerated in Kv2.1N216FLAG-expressing ventricular myocytes or, alternatively, that there are 2 components of I K, slow in wild-type cells (that inactivate at different rates) and that one of these is attenuated, or eliminated, in the Kv2.1N216FLAG-expressing transgenic mice (see Discussion). Analysis of the decay phases of the outward currents also revealed that the density of the slow component of current decay in Kv2.1N216FLAG-expressing ventricular cells is significantly (PϽ0.01) lower than in wild-type cells; meanϮSEM I K, slow densities (at ϩ40 mV) were 8.7Ϯ1.3 pA/pF and 15.6Ϯ1.6 pA/pF in ventricular cells isolated from transgenic (nϭ17) and nontransgenic (nϭ25) littermates, respectively ( Table 1 ). The voltage-dependent properties of the currents, however, are unaffected, and I K, slow density is significantly lower at all test potentials in the Kv2.1N216FLAG-expressing, than in wild-type, cells ( Figure  3E ). No significant differences in the densities or in the properties of I to, f (or I ss ) densities were observed (Table 1 ; Figure 3E ), suggesting that I K, slow is selectively attenuated in ventricular myocytes isolated from adult Kv2.1N216FLAG-expressing transgenic animals (see Discussion).
Pharmacological Properties of I K, slow in Kv2.1N216FLAG-Expressing Ventricular Myocytes
In wild-type mouse ventricular myocytes, I K, slow is blocked by mol/L concentrations of 4-aminopyridine (4-AP) 15, 32, 33 and by mmol/L concentrations of tetraethylammonium (TEA) 15 ; I ss is also partially blocked by millimolar concentrations of TEA but is unaffected by 4-AP at concentrations Յ1 mmol/L. 15 Exposure of adult mouse ventricular myocytes to concentrations of 4-AP Ͼ100 mol/L leads to further block of I K, slow and also blocks I to, f . In the presence of 0.5 mmol/L 4-AP, for example, I to, f is attenuated by Ϸ50% and I K, slow is blocked completely. 15 Experiments were completed, therefore, to determine the pharmacological properties of the slowly inactivating outward current (I K, slow ) remaining in Kv2.1N216FLAG-expressing ventricular myocytes (Figure 4) . After recording control currents ( Figure 4A ), cells were exposed sequentially to 25 mmol/L TEA followed by 50 mol/L 4-AP, and the currents in the presence of 25 mmol/L TEA ( Figure 4B ) and 50 mol/L 4-AP ( Figure  4C ) were recorded. The waveforms of the 25 mmol/L TEA-sensitive ( Figure 4D ) or the 50 mol/L 4-AP-sensitive ( Figure 4E ) components of the currents were then determined by subtracting the currents in the presence of 25 mmol/L TEA ( Figure 4B ) or 50 mol/L 4-AP ( Figure 4C ) from the controls ( Figure 4A) .
Analysis of the 25 mmol/L TEA-sensitive currents ( Figure  4D ) reveals that activation is slow and that the currents undergo little or no inactivation during the 4.5-second voltage steps. The waveforms of the 25 mmol/L TEA-sensitive currents are consistent with block of I ss . 15 In wild-type cells, the decay phases of the 25 mmol/L TEA-sensitive currents are well described by single exponentials with a meanϮSEM decay of 1234Ϯ197 ms (nϭ4), an observation interpreted as reflecting TEA block of I K, slow in these cells. 15 In wild-type cells, both I ss and I K, slow are reduced by Ϸ60% in 25 mmol/L TEA (and I to, f is unaffected). 15 The inactivating component of the TEA-sensitive currents seen in wild-type cells, however, is not evident in the Kv2.1N216FLAG-expressing cells (Figure 4D) , suggesting that Kv2 subunits underlie this (TEAsensitive) component of I K, slow (see Discussion). Similar to findings in wild-type cells, 15, 23, 32, 33 the waveforms of the 50 mol/L 4-AP-sensitive currents in Kv2.1N216FLAG-expressing cells ( Figure 4E ) are consistent with the selective attenuation of I K, slow . Taken together, these results suggest that the component of I K, slow sensitive to mol/L concentrations of 4-AP remains in the Kv2.1N216-expressing ventricular myocytes, whereas the TEA-sensitive component of I K, slow is eliminated (see Discussion).
Action Potentials and QT Intervals Are Prolonged in the Kv2.1N216FLAG-Expressing Animals
Current-clamp experiments revealed that action potentials recorded from Kv2.1N216FLAG-expressing ventricular myocytes are substantially broader than action potentials recorded from cells isolated from nontransgenic littermates ( Figure 5A ), with the latter phase of repolarization being particularly affected ( Figure 5A ). Analysis of action potential durations at 25% (APD 25 ), 50% (APD 50 ), 75% (APD 75 ), and 90% (APD 90 ) repolarization indeed revealed that only meanϮSEM APD 90 values were increased significantly (PϽ0.01) in Kv2.1N216FLAG-expressing ventricular cells (Table 2) . MeanϮSEM APD 90 values were 34Ϯ5 ms (nϭ16) and 54Ϯ6 ms (nϭ22) in wild-type and Kv2.1N216FLAG-expressing cells, respectively (Table 2 ). In contrast, APD 25 , APD 50 , and APD 75 values in transgenic and nontransgenic cells are not significantly different (Table 2 ). In addition, action potential amplitudes and resting membrane potentials of the Kv2.1N216FLAG-expressing myocytes are not significantly different from those measured in wild-type cells ( Table 2 ). The action potential prolongation seen in the Kv2.1N216FLAG-expressing ventricular cells, however, is substantially less than that observed in Kv4.2W362F-expressing mouse ventricular myocytes, which lack I to, f , 19 and in Kv1.1N206Tag-expressing cells, in which I K, slow is also attenuated 32 (see Discussion). Unexpectedly, triggered activity, presumably resulting from early afterdepolarizations, was observed in 4 of the 22 transgenic Kv2.1N216FLAG-expressing ventricular cells studied ( Figure 5B ).
Although meanϮSEM APD 90 values are increased significantly in Kv2.1N216FLAG-expressing transgenic mice, considerable variability was observed among cells. This point is clearly evident in the histogram in Figure 6 , in which APD 90 values determined in individual cells are displayed. In the majority (13 of 16, or 80%) of the wild-type cells, APD 90 values are Ͻ50 ms, and in only 1 cell was the APD 90 Ͼ60 ms ( Figure 6 ). The measured APD 90 values were not correlated with differences in resting membrane potentials and are assumed to reflect variability among cells in the absolute densities of the depolarization-activated K ϩ currents, I to, f , I K, slow , and I ss , that underlie repolarization (see Discussion). In the Kv2.1N216FLAG-expressing cells, in contrast, APD 90 values Ͼ50 ms were measured in half (11 of 22) of the cells (Figure 6) , and, in 4 of these cells, the APD 90 exceeded 90 ms, ie, was significantly longer than that observed in any of the wild-type cells ( Figure 6 ). These observations are consistent with the variable attenuation in I K, slow in the Kv2.1N216FLAG-expressing ventricular myocytes (Table 1) .
To determine the functional consequences of the prolongation of ventricular action potentials, telemetric electrocardiographic recordings were obtained from Kv2.1N216FLAG-expressing transgenic and nontransgenic (wild-type) littermates (see Materials and Methods). Typical electrocardiographic recordings from wild-type and Kv2.1N216FLAG transgenic mice are presented in Figure 7 . As is immediately evident on visual inspection of the records, there is a marked prolongation of the QT interval in the transgenic animals, consistent with a defect in ventricular repolarization. MeanϮSEM QT intervals in wild-type and transgenic animals were found to equal 27Ϯ4 ms (nϭ5) and 42Ϯ5 ms (nϭ7), respectively; these values are significantly (PϽ0.001) different. Neither heart rates (RR intervals) nor QRS durations, however, were affected by Kv2.1N216FLAG expression. MeanϮSEM RR intervals were 100Ϯ6 ms (nϭ5) and 102Ϯ9 ms (nϭ7) in wild-type and Kv2.1N216FLAG-expressing animals, respectively; meanϮSEM QRS durations were 8Ϯ1 ms (nϭ5) and 8Ϯ2 ms (nϭ7) in control and transgenic animals, respectively. When QT intervals were corrected for heart rate, 32 the differences between the transgenic and the nontransgenic animals remained highly significant (at the PϽ0.001 level); meanϮSEM QT c intervals (see Materials and Methods) were 27Ϯ5 ms (nϭ5) and 42Ϯ4 ms (nϭ7) in control and Kv2.1N216FLAG-expressing animals, respectively. Interestingly, the QT prolongation seen in the Kv2.1N216FLAG-expressing cells is substantially less than that observed in Kv4.2W362F-expressing mouse ventricular myocytes, which lack I to, f , 19, 23 and in Kv1.1N206Tag-expressing cells, in which I K, slow is also attenuated 32 (see Discussion). As might be expected from the finding of triggered activity in single ventricular myocytes ( Figure 5B ), premature ventricular beats were observed in the electrocardiographic recordings from 2 of the 7 Kv2.1N216FLAG-expressing animals (see Discussion).
Discussion Functional Consequences of Cardiac-Specific Expression of Kv2.1N216FLAG
The results presented here reveal that the density of the slow component of current decay, referred to as I K, slow in wild-type mouse ventricular cells, 15, 23, [32] [33] [34] is reduced significantly in ventricular myocytes isolated from Kv2.1N216FLAG-expressing animals. The effect on I K, slow is specific in that neither I to, f nor I ss is affected, suggesting that members of the Kv2 ␣ subunit subfamily contribute to the slow component of delayed rectification in the mouse ventricle. This finding was unexpected, because it has previously been reported that mouse ventricular I K, slow is eliminated or markedly reduced 32, 34 in cells isolated from transgenic mice expressing a truncated Kv1.1 subunit, Kv1.1N206Tag, an observation that was interpreted as suggesting that members of the Kv1 subfamily of ␣ subunits underlie I K, slow . These combined, and seemingly conflicting, observations could reflect strain differences in that the experiments described here were completed on C57BL/6 mice, whereas those of London et al 32 were completed on FVB mice. This hypothesis, however, seems unlikely given that the properties of the various currents in ventricular myocytes isolated from these 2 strains appear to be indistinguishable. 15, 19, 23, 32, 34 Rather, it seems more likely that there are 2 components of I K, slow in wild-type adult mouse ventricular myocytes, with similar, but not identical, properties. In support of this hypothesis, the fraction of I K, slow remaining in the Kv2.1N216FLAG-expressing ventricular cells is blocked by 50 mol/L 4-AP but is insensitive to 25 mmol/L TEA, whereas wild-type I K, slow is attenuated to Ϸ50% of control by 25 mmol/L TEA, as well as by 50 mol/L 4-AP. Taken together, these results suggest that the component of I K, slow sensitive to mol/L concentrations of 4-AP remains in the Kv2.1N216-expressing ventricular myocytes, whereas the TEA-sensitive component of I K, slow is eliminated. If this interpretation is correct and the currents in wild-type C57BL/6 and FVB mice are indeed indistinguishable, it follows that a component of I K, slow remains in the Kv1.1N206Tag-expressing ventricular cells and that this component reflects the expression of (TEA-sensitive) Kv2 ␣ subunits. Further experiments focused on testing this hypothesis directly and on examining the pharmacological properties of the depolarization-activated outward K ϩ currents in the Kv1.1N206Tag-expressing transgenic mice would clearly be of interest.
The results presented here also demonstrate that the rate of inactivation of the slow component of current decay in ventricular cells isolated from the Kv2.1N216FLAG-expressing animals is faster than observed (for I K, slow ) in wild-type ventricular cells. Again, the simplest interpretation of this finding is that there are 2 components of I K, slow and that the faster component of I K, slow remains in Kv2.1N216FLAG-expressing cells. If this is correct, it also follows that there is a component of I K, slow remaining in Kv1.1N206Tag-expressing ventricular cells and that the time constant of inactivation of this component of I K, slow (attributed to Kv2 ␣ subunit expression) must be Ϸ1100 ms, ie, similar to the mean decay for I K, slow in wild-type cells (Table 1) . Further experiments aimed at testing these hypotheses directly are clearly warranted. In addition, it would be of interest to cross the Kv1.1N206Tag-and the Kv2.1N216FLAG-expressing transgenic mice to test the prediction that both components of I K, slow will be eliminated in ventricular myocytes isolated from animals expressing both transgenes.
Current-clamp experiments revealed that APD 90 values are increased significantly in Kv2.1N216FLAG-expressing ventricular myocytes, consistent with the attenuation of I K, slow . In addition, triggered activity, presumably resulting from early afterdepolarizations, was observed in 4 of the 22 Kv2.1N216FLAG-expressing ventricular cells studied. The attenuation of I K, slow also results in prolongation of the QT interval, and in 2 of the 7 Kv2.1N216FLAG-expressing animals, premature ventricular beats were recorded. Expression of Kv2.1N216FLAG, however, does not appear to have any other profound physiological or pathophysiological consequences. In fact, the Kv2.1N216FLAG-expressing animals appear normal in every respect and, in experiments completed to date, we find no evidence that these animals are prone to develop arrhythmias. Interestingly, the increases in action Figure 7 . Prolongation of the QT interval is evident in electrocardiographic recordings from Kv2.1N216FLAG-expressing mice. ECGs were recorded as described in Materials and Methods with electrode position optimized to permit reliable resolution of the T waves and accurate measurements of QT intervals. P, QRS, and T waves and the QT intervals are clearly labeled in the records obtained from the nontransgenic and Kv2.1N216FLAG-expressing mice.
potential durations seen in the Kv2.1N216FLAG-expressing ventricular cells and the QT prolongation in Kv2.1N216FLAG-expressing animals are substantially less than those seen in either the Kv4.2W362F-expressing transgenic mouse ventricular myocytes, which lack I to, f , 19 or the Kv1.1N206Tag-expressing cells, in which I K, slow is attenuated. 32 Presumably, these difference reflect the kinetic properties and the densities of the various K ϩ currents (ie, I to, f and the fast and slow components of I K, slow ) that are affected in Kv4.2W362F-, 19 Kv1.1N206Tag-, 32 and Kv2.1N216FLAG-expressing transgenic animals, respectively. It is certainly also possible that there are additional changes (such as in the properties and/or the functional expression of other ion channels, pumps, or carriers) that occur in the ventricles of these transgenic animals, and that these, in turn, contribute to prolonged action potential waveforms and QT intervals. Overexpression of the Na ϩ -Ca 2ϩ exchanger, for example, leads to profound changes in the waveforms of mouse ventricular action potentials. 43 Further experiments will be necessary to explore this possibility directly.
Relationship to Previous Studies
As noted above, London et al 32 reported the generation and characterization of long-QT mice 32 expressing a truncated Kv1.1 subunit, Kv1.1N206Tag, that functions as a dominant negative. 35 When expressed in GH3 cells, Kv1.1N206Tag coassembles with endogenous Kv1.4 and Kv1.5, and the resulting heteromeric channel complexes appear to be retained in the endoplasmic reticulum, rather than being transported to the plasma membrane or targeted for degradation. 35 The finding that Kv1.1N206Tag expression attenuates mouse ventricular I K, slow was interpreted as suggesting that Kv1 ␣ subunits underlie I K, slow . 32, 35 The sensitivity of I K, slow to mol/L concentrations of 4-AP, 32, 33 and the finding that Kv1.5 protein levels are reduced in Western blots of fractionated (crude) ventricular membrane proteins from Kv1.1N206Tag-expressing transgenic mice led to the specific hypothesis that Kv1.5 is the Kv1 subfamily member that underlies I K, slow . 32 The loss of Kv1.5 protein in these animals, however, is unexpected given that steady-state Kv1.4 and Kv1.5 protein levels in GH3 cells were unaffected by Kv1.1N206Tag expression. 35 These results also contrast with the results described here demonstrating that the steady-state level of Kv2.1 protein expression is not measurably altered in the ventricles of Kv2.1N216FLAG-expressing transgenic mice. Further experiments will be necessary to explore the molecular basis of these differences.
Cardiac-specific expression of Kv1.1N206Tag also results in prolonged ventricular action potentials and QT intervals, increased frequency of premature ventricular beats, ventricular arrhythmias, and spontaneous ventricular tachyarrhythmias. 32 Triggered activity was seen in 4 of 22 Kv2.1N216FLAG-expressing ventricular myocytes, and premature ventricular beats were recorded in 2 of the 7 animals monitored; no evidence for ventricular arrhythmia, however, was obtained. Interestingly, the increases in action potential durations and QT intervals observed in the Kv1.1N206Tag-expressing animals are greater than observed here in the Kv2.1N216FLAG transgenic mice, and this may account for the more dramatic phenotype seen in the Kv1.1N206Tag-expressing animals. In this context, it is of interest to note that the prolongation of ventricular action potentials and QT intervals observed in Kv4.2W362F-expressing transgenic mice, which lack I to, f , 19 are larger than in the Kv1.1N206Tag transgenic mice, 32 and there is no evidence for triggered activity, premature beats, or spontaneous arrhythmias in these (KV4.2W362F) animals. 19 Taken together, these results suggest that factors, in addition to prolonged ventricular repolarization, play an important role in determining the propensity to develop and to sustain arrhythmias. Studies focused on exploring the molecular mechanisms underlying the markedly different phenotypes of mice expressing Kv4.2W362F, 19 Kv2.1N216FLAG, and Kv1.1N206Tag 32 are clearly warranted.
